Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about EDIT

Recent news which mentions EDIT

< Previous 1 2 3 4 5 6 7 8 Next >
Could Editas Medicine Become the Next CRISPR Therapeutics?
Tickers CRSP EDIT
Tags Recent Press Releases Market News EDIT
From Motley Fool
7 Mighty Healthcare Stocks Changing the Game of Medicine
Tickers ASXC EDIT HOLX ILMN
Tags VERV NASDAQ:ILMN,NASDAQ:HOLX,NASDAQ:HOLX,NASDAQ:MRNA,NASDAQ:EDIT,NASDAQ:VERV,NYSEAMERICAN:ASXC Stocks to Buy
From InvestorPlace
Down 88%, Could Editas Medicine Be a Good Investment Now?
Tickers CRSP EDIT VRTX
Tags Market News Recent Press Releases EDIT
From Motley Fool
3 Stocks to Buy in the Booming Field of Gene Editing
Tickers BEAM EDIT LLY VERV
Tags VERV VRTX Market News
From InvestorPlace
Better Gene-Editing Stock: Editas Medicine vs. Intellia Therapeutics
Tickers EDIT NTLA
Tags NTLA EDIT Recent Press Releases
From Motley Fool
Editas Just Caught a Break Thanks to Vertex Pharmaceuticals
Tickers EDIT VRTX
Tags VRTX EDIT Recent Press Releases
From Motley Fool
Vertex’s stock heads for all-time high as non-opioid painkiller shows promise
Tickers EDIT SPX VRTX VTRS
Tags SPX VTRS EDIT
From MarketWatch
The Latest Analyst Ratings for Editas Medicine
Tickers EDIT
Tags EDIT Analyst Ratings Benzinga
From Benzinga
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment
Tickers BLUE CRSP EDIT VRTX
Tags CRSP EDIT BLUE
From MarketWatch
1 Promising Stock Down 66% That Could Skyrocket in 2024
Tickers EDIT
Tags Recent Press Releases Market News EDIT
From Motley Fool
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
Tickers ARKG BEAM CRBU CRSP
Tags PRME VERV CRBU
From Motley Fool
If You Can Only Buy One Biotech Stock in December, It Better Be One of These 3 Names
Tickers BLUE EDIT GPCR
Tags EDIT GPCR BLUE
From InvestorPlace
Hidden Gems for Hefty Returns: 3 Stocks Set to Double Your Wealth Next Year
Tickers AMD EDIT MARA
Tags Market News Stocks to Buy NASDAQ:AMD,NASDAQ:MARA,NASDAQ:EDIT
From InvestorPlace
The 3 Best Gene Editing Stocks on the Frontier of Medicine
Tickers ARKG BEAM EDIT
Tags BEAM Stocks to Buy Market News
From InvestorPlace
2 Beaten-Down Growth Stocks That Could Rocket 42% to 67% Higher, According to Wall Street
Tickers AAPL BLUE CRSP EDIT
Tags Recent Press Releases MSFT BLUE
From Motley Fool
3 Long-Term Growth Stocks Analysts Are Bullish On
Tickers CRSP EDIT NVDA SQ
Tags EDIT SQ CRSP
From InvestorPlace
3 Biotech Stocks That Are Betting on the Future of Gene Editing
Tickers CRSP EDIT NTLA REGN
Tags Stocks to Buy Market News CRSP
From InvestorPlace
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Tickers AGL ALLO AMCX ATGL
Tags FTNT RDFN SQ
From Benzinga
Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday
Tickers ALLO AMCX AXL CAH
Tags IT FNKO PRLB
From Benzinga
Earnings Scheduled For November 3, 2023
Tickers ACRE AMCX ARQT ASIX
Tags BZI/UE IEP MG
From Benzinga
A Preview Of Editas Medicine's Earnings
Tickers EDIT
Tags Earnings Benzinga BZI/EP
From Benzinga
Sent Your Boss The Message Meant For Your Girlfriend On Instagram — Now You Can Save Your Bacon
Tickers EDIT META TECH X
Tags Instagram Meta Tech
From Benzinga
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient
Tickers AMGN BLUE CRSP EDIT
Tags Market News VRTX AMGN
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
Tickers ABNB ALKS AMZN ANL
Tags ALKS RRC BZI/Ratings
From Benzinga
3 Gene Editing Stocks to Generate Super-Charged Gains
Tickers BEAM CRSP EDIT GNOM
Tags EDIT NTLA NASDAQ:EDIT,NASDAQ:CRSP,NASDAQ:GNOM,NASDAQ:VRTX,NASDAQ:SRPT,NASDAQ:NTLA,NASDAQ:BEAM
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023
Tickers ALB ALPN ARM BIP
Tags NKTX ALB Market News
From Benzinga
1 Risky Biotech Stock to Consider Buying, and 1 to Avoid
Tickers BEAM EDIT
Tags EDIT BEAM Recent Press Releases
From Motley Fool
Analyst Ratings for Editas Medicine
Tickers EDIT
Tags EDIT Market News BZI/AAR
From Benzinga
Editas Medicine Has To Navigate Sickle Cell Therapy Competition: Analyst
Tickers BLUE CRSP EDIT
Tags Biotech Analyst Ratings BLUE
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
Tickers ACA ACAD ACDC ACLX
Tags ENB WHD TYL
From Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.